6.21MMarket Cap-0.13P/E (TTM)
1.3200High1.2807Low25.15KVolume1.3000Open1.3050Pre Close32.75KTurnover0.53%Turnover RatioLossP/E (Static)4.78MShares9.790052wk High1.26P/B6.21MFloat Cap1.220152wk Low--Dividend TTM4.77MShs Float3118.4994Historical High--Div YieldTTM3.01%Amplitude1.2201Historical Low1.3010Avg Price1Lot Size
Phio Pharmaceuticals Stock Forum
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical's Clinical Research at 2025 Annual Meeting
Can Phio's INTASYL Technology Transform Skin Cancer Treatment? Trial Reaches Key Milestone
Benzinga· just
Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study
Wednesday, 5th March at 7:45 am
Marlborough, Massachusetts--(Newsfile Corp. - March 5, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells. Phio ...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, I...
No comment yet